LENZ Therapeutics, Inc. (LENZ) › Net IncomeLENZ Therapeutics, Inc. (LENZ) — Net IncomeAnnual figures by period end, from SEC filings.2020-12-31: -$68.37M2021-12-31: -$70.76M2022-12-31: -$101.05M2023-12-31: -$69.97M2024-12-31: -$49.77M2025-12-31: -$82.13M-$82.13M2020-12-31Net Income (USD)2025-12-31Period endedNet IncomeChange YoYSource filing2025-12-31-$82.13M—2026-03-24From 2025-01-012024-12-31-$49.77M—2026-03-24From 2024-01-012023-12-31-$69.97M—2025-03-19From 2023-01-012022-12-31-$101.05M—2024-02-27From 2022-01-012021-12-31-$70.76M—2023-03-20From 2021-01-012020-12-31-$68.37M—2022-03-21From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)